Michael Smolinski
Plus aucun poste en cours
Historique de carrière de Michael Smolinski
Anciens postes connus de Michael Smolinski
Sociétés | Poste | Début | Fin |
---|---|---|---|
ATHENEXPAR | Directeur Technique/Scientifique/R&D | 01/01/2008 | 01/05/2022 |
Homecare Homebase LLC
Homecare Homebase LLC Packaged SoftwareTechnology Services Homecare Homebase LLC provides enterprise management software to clients in the healthcare industry. It offers cloud-based solutions for data exchange, communications, claims processing, billing, and logistics, as well as systems implementation, training, and technical support services. The company was founded by April K. Anthony in 1999 and is headquartered in Dallas, TX. | Directeur Technique/Scientifique/R&D | - | - |
Formation de Michael Smolinski
State University of New York at Buffalo | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Sectorielle
Technology Services | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Homecare Homebase LLC
Homecare Homebase LLC Packaged SoftwareTechnology Services Homecare Homebase LLC provides enterprise management software to clients in the healthcare industry. It offers cloud-based solutions for data exchange, communications, claims processing, billing, and logistics, as well as systems implementation, training, and technical support services. The company was founded by April K. Anthony in 1999 and is headquartered in Dallas, TX. | Technology Services |
Athenex, Inc.
Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
- Bourse
- Insiders
- Michael Smolinski
- Expérience